SHC
Overvalued by 141.2% based on the discounted cash flow analysis.
Market cap | $4.65 Billion |
---|---|
Enterprise Value | $6.81 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $0.16 |
Beta | 1.81 |
Outstanding Shares | 283,933,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 193.48 |
---|---|
PEG | -2155.89 |
Price to Sales | 5.21 |
Price to Book Ratio | 15.62 |
Enterprise Value to Revenue | 6.05 |
Enterprise Value to EBIT | 32.48 |
Enterprise Value to Net Income | 283 |
Total Debt to Enterprise | 0.37 |
Debt to Equity | 4.87 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...